Select a metric from the list below to chart it
Mar '21
Mar '22
Mar '23
LTM
Metric | Mar '21 | Mar '22 | Mar '23 | LTM |
|---|---|---|---|---|
Total Revenues | 2,027.0 | 2,703.0 | 2,679.0 | 2,838.0 |
Total Revenues % Chg. | — | 33.3% | -0.9% | 40.0% |
Cost of Goods Sold, Total | 145.0 | 131.0 | 106.0 | 133.0 |
Gross Profit | 1,882.0 | 2,572.0 | 2,573.0 | 2,705.0 |
Selling General & Admin Expenses, Total | 826.0 | 897.0 | 722.0 | 883.0 |
R&D Expenses | 814.0 | 995.0 | 1,133.0 | 1,630.0 |
Other Operating Expenses | — | — | 5.5 | 5.5 |
Other Operating Expenses, Total | 1,640.0 | 1,892.0 | 1,860.5 | 2,518.5 |
Operating Income | 242.0 | 680.0 | 712.5 | 186.5 |
Interest And Investment Income | 2.0 | 2.0 | 42.0 | 86.0 |
Net Interest Expenses | 2.0 | 2.0 | 42.0 | 86.0 |
Income (Loss) On Equity Invest. | 476.0 | 141.0 | -45.0 | 17.0 |
Currency Exchange Gains (Loss) | 21.0 | -17.0 | -30.0 | — |
Other Non Operating Income (Expenses) | -41.0 | 27.0 | 33.0 | -11.0 |
EBT, Excl. Unusual Items | 700.0 | 833.0 | 712.5 | 278.5 |
Restructuring Charges | — | -26.0 | -1.5 | 2.5 |
Asset Writedown | -3.0 | -21.0 | — | — |
Legal Settlements | — | — | -40.0 | -40.0 |
EBT, Incl. Unusual Items | 697.0 | 786.0 | 671.0 | 241.0 |
Income Tax Expense | 153.0 | 110.0 | 147.0 | 61.0 |
Earnings From Continuing Operations | 544.0 | 676.0 | 524.0 | 180.0 |
Earnings Of Discontinued Operations | -156.0 | -127.0 | — | — |
Net Income | 388.0 | 549.0 | 524.0 | 180.0 |
Net Income to Common Incl Extra Items | 388.0 | 549.0 | 524.0 | 180.0 |
Net Income to Common Excl. Extra Items | 544.0 | 676.0 | 524.0 | 180.0 |
Total Shares Outstanding | 1,025.2 | 1,025.2 | 1,025.2 | 1,025.2 |
Weighted Avg. Shares Outstanding | 1,025.2 | 1,025.2 | 1,025.2 | 1,025.3 |
Weighted Avg. Shares Outstanding Dil | 1,025.2 | 1,025.2 | 1,027.5 | 1,026.9 |
EPS | 0.4 | 0.5 | 0.5 | 0.2 |
EPS Diluted | 0.4 | 0.5 | 0.5 | 0.2 |
EBITDA | 422.0 | 857.0 | 882.5 | 351.5 |